US Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday that the Covid-19 vaccine will no longer be ...

The U.S. Food and Drug Administration last week said it plans to require new clinical trials for approval of annual COVID-19 ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...

Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system was approved by the FDA and indicated for those with ...

In patients with eosinophilic esophagitis, etrasimod led to sustained histologic and endoscopic improvement over a year, with ...

"Patients presenting with chronic diarrhea, blood in the stool, unexplained nausea and vomiting, or unexplained weight loss ...

Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on PFE stock here.

Pfizer (PFE 0.77%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

The project will feature more than 100,000ft² of amenities and approximately 30,000ft² of ground-floor retail space.

The announcement reverses previous CDC advice. At the time of the announcement, the CDC’s webpage still contained its ...

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...